| Steve Eric Sorensen, DDS,MS | |
|
4587 Cedar Hills Dr, Cedar Hills, UT 84062-8826 | |
| (801) 756-2006 | |
| Not Available |
| Full Name | Steve Eric Sorensen |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 4587 Cedar Hills Dr, Cedar Hills, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184815664 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 6456209-8903 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Steve Eric Sorensen, DDS,MS 4587 Cedar Hills Dr, Cedar Hills, UT 84062-8826 Ph: (801) 756-2006 | Steve Eric Sorensen, DDS,MS 4587 Cedar Hills Dr, Cedar Hills, UT 84062-8826 Ph: (801) 756-2006 |
News Archive
Although trauma, heart and stroke patients benefit from being transferred from a local hospital to a higher-level care facility, it's unclear why patients transferred with non-urgent medical conditions show at least a 30 percent higher death rate than had they stayed put, according to researchers from Case Western Reserve University's nursing school.
A novel microarray-based 18-gene expression tool known as ColoPrint significantly improves prognostic accuracy in stage II colon cancer patients who have undergone surgery, suggest study findings.
A new special section of Child Development shows how particularly diverse the use of mobile technology is among children and adolescents, and points to great complexity in the effects of that usage.
A new study suggests that people with brain injuries following head trauma may have buildup of the plaques related to Alzheimer's disease in their brains. The research is published in the February 3, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.
Peregrine Pharmaceuticals, Inc. (PPHM) today reported publication of data in the online edition of the journal Current Cancer Therapy Reviews that supports the clinical potential of the company's novel brain cancer agent Cotara® for the treatment of patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara specifically targets cells at the center of brain tumors, so its radioactive payload is able to kill cancer cells while leaving healthy tissue largely unaffected. Cotara is currently being tested in a Phase II clinical trial in recurrent GBM patients.
› Verified 2 days ago
Dr. James Carver Standring, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 4587 W Cedar Hills Dr, Suite #100, Cedar Hills, UT 84062 Phone: 801-756-2006 Fax: 801-756-0821 | |
Craig Young, DMD, MS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4587 W Cedar Hills Dr Ste 200, Cedar Hills, UT 84062 Phone: 801-642-0995 | |
Dr. Michael Sean Lorscheider, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 10060 N 4600 W, Cedar Hills, UT 84062 Phone: 801-492-0402 Fax: 801-492-0414 | |
Dr. Brian Edward Isaacson, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 4565 Cedar Hills Dr, Cedar Hills, UT 84062 Phone: 801-756-9154 Fax: 801-756-9199 | |
Dr. William Edward Isaacson, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 4565 Cedar Hills Dr, Cedar Hills, UT 84062 Phone: 801-756-9154 Fax: 801-756-9199 | |
Dr. John R Lohner, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 4587 W Cedar Hills Dr, Cedar Hills, UT 84062 Phone: 801-756-2006 |